Semi-closed Loop Automated Insulin Therapy in the Pediatric Population Aged 2-6 Years With Type 1 Diabetes: Impact on Quality of Life and Glycemic Control

Recruiting now

Conditions studied: Type 1 Diabetes, Closed Loop, Insulin, Quality of Life, Pediatric

In brief

The incidence of type 1 diabetes is increasing, with an incidence of +4% per year in France today. The treatment for type 1 diabetes is insulin therapy. In recent years, new systems have emerged, so-called "semi-closed loop" systems, also called automated insulin therapy, which have proven their superiority in terms of quality of life and glycemic balance in adults and children over 6 years old. Since January 24, 2024, the HAS now recognizes the indication of the semi-closed loop for the YPSOPUMP model in children aged 2 to 6 years. This is the first reimbursement in France of a closed loop system for the 2-6 year old age group. There are currently few studies comparing the quality of life of children in semi-closed loop versus other treatments (open loop or injections). Regarding quality of life, the studies found mainly concern the contribution for parents and the improvement of adolescents' sleep as in the study by Erin C Cobry et al from 2020 (6). Our study therefore aims to demonstrate an improvement in quality of life but also in diabetes balance in type 1 diabetic patients on a closed loop insulin pump versus open loop or injections in the pediatric population aged 2-6 years.

Key facts

Study ID

NCT06875167

Run by

Fondation Lenval

People needed

20

Starts

2025-03-17

Expected to finish

2026-12-01

Last updated by the study team

2025-04-20

Who can join

Age: 2 and older, up to 6. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• -Patients aged 2 to 6 years inclusive
• Presenting type 1 diabetes on insulin therapy
• Social security affiliates
• Patient initiating semi-closed loop treatment
• Family (at least one parent or representative of parental authority) agreeing to follow the training necessary for continuous measurement of glucose in real time.
• collection of non-opposition from one of the two parents or the representative of parental authority agreement

You may not qualify if…

• Opposition to participation in research involving humans or opposition to the use of data or samples and associated data (withdrawal of non-opposition).

Where it is running

• Fondation Lenval Hôpitaux pédiatrique Nice CHU Lenval — Nice, France, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.